Multiomic Lung Cancer Screening Test | Positive Early Data

NEWS & RESOURCES

PrognomiQ Aims to Launch Multiomic Lung Cancer Screening Test Buoyed by Positive Early Data

genomeweb logo

PrognomiQ, a spinoff of proteomics technology firm Seer, hopes to launch its first test, a blood-based lung cancer screening assay, within a year after completing a large case-control study that it published in a recent preprint.

Read the full article on GenomeWeb here.

Share this page: